XSUS:CA:TSX-iShares ESG MSCI USA Index ETF (CAD)

ETF | US Equity |

Last Closing

CAD 23.01

Change

-0.31 (-1.33)%

Market Cap

CAD 0.01B

Volume

1.60K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-01-27 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
ZSP:CA BMO S&P 500

-0.77 (-1.02%)

CAD 10.81B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-0.46 (-0.88%)

CAD 9.71B
VFV:CA Vanguard S&P 500 Index ETF

-1.24 (-1.01%)

CAD 8.89B
VUN:CA Vanguard US Total Market

-0.84 (-0.91%)

CAD 7.76B
XUS:CA iShares Core S&P 500 Index ETF

-0.87 (-1.02%)

CAD 5.73B
HXS:CA Horizons S&P 500 Index ETF

-0.82 (-1.17%)

CAD 2.95B
QUU:CA Mackenzie US Large Cap Equity ..

-2.16 (-1.09%)

CAD 2.89B
XUU:CA iShares Core S&P US Total Mark..

-0.49 (-0.96%)

CAD 2.68B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

-2.73 (-2.07%)

CAD 2.66B
VSP:CA Vanguard S&P 500 CAD hedged

-0.73 (-0.89%)

CAD 2.45B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.54% 72% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.54% 72% C 73% C
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A F
Risk Adjusted Return N/A N/A N/A N/A F
Market Capitalization 0.01B 11% F 8% B-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.